IL1B and osteoarthritis: In contrast, interleukin 1β (IL-1β) is a cytokine and a key mediator of the inflammatory response that is associated with the activation of catabolic pathways in cartilage and chondrogenesis inhibition, leading the cartilage tissue to degradation and osteoarthritis (OA) development [9,10,11,12].